| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Operating Officer
2 companies
Bruno Julianne serves as a Director at GLTO and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $435K at current prices.
Historically, Bruno Julianne's trades have earned a below-average insider score of 48/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -4.8%.
The biggest single holding is CRSP (~$435K) as Chief Operating Officer. The recent filings there lean toward selling, a net 6,801 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 1,714 | $41.23 | $70,668.22 | -14.0% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 1,388 | $42.54 | $59,049.96 | -14.0% | -1.3% | +12.4% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 333 | $52.80 | $17,582.40 | -4.5% | -26.0% | +3.1% | |
| Jun 21, 2024 | CRSP Crispr Therapeutics AG | Chief Operating Officer | Sale+OE | 3,366 | $56.09 | $188,798.94 | -33.3% | -12.0% | -21.3% |